Showing 49–64 of 295 results
Assesses blood lipids for cardiovascular risk stratification.
The ANTI STREPTOLYSIN – O (ASO) test measures specific biomarkers related to anti streptolysin – o (aso) for diagnosis and monitoring.
The ANTI THYROGLOBULIN ANTIBODY (ATG) test measures specific biomarkers related to anti thyroglobulin antibody (atg) for diagnosis and monitoring.
Anti‑TPO antibodies for autoimmune thyroid disease evaluation.
The ANTIDNASE-B (DNB) test measures specific biomarkers related to antidnase-b (dnb) for diagnosis and monitoring.
The ANTINUCLEAR ANTIBODIES-17 BLOT test measures specific biomarkers related to antinuclear antibodies-17 blot for diagnosis and monitoring.
The ANTITHROMBIN III test measures specific biomarkers related to antithrombin iii for diagnosis and monitoring.
The APOLIPOPROTEIN – A1 (APO-A1) test measures specific biomarkers related to apolipoprotein – a1 (apo-a1) for diagnosis and monitoring.
The APOLIPOPROTEIN – B (APO-B) test measures specific biomarkers related to apolipoprotein – b (apo-b) for diagnosis and monitoring.
Aspartate aminotransferase—hepatocellular and muscle injury marker.
The BARBITURATES test measures specific biomarkers related to barbiturates for diagnosis and monitoring.
The BARIUM test measures specific biomarkers related to barium for diagnosis and monitoring.
The BENZODIAZEPINES test measures specific biomarkers related to benzodiazepines for diagnosis and monitoring.
The BERYLLIUM test measures specific biomarkers related to beryllium for diagnosis and monitoring.
The BETA 2 GLYCOPROTEIN 1 – IGG test measures specific biomarkers related to beta 2 glycoprotein 1 – igg for diagnosis and monitoring.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
You can find more information in our Cookie Policy.
Your Cart is Empty
